Evidence map›Paper›PMID 40860882›Full record

ReviewFrontiers in pharmacology2025

Nanoengineered-based delivery systems to modulate CD4

Nekhat Shahreen, Anukrati Agnihotri, Asfi Rizwan, Faizul Hasan, Mohd Danish Ansari, Zarif Mohamed Sofian, Nur Akmarina B M Said, Kenneth K W To, Syed Mahmood

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nekhat ShahreenSchool of Pharmaceutical Education and Research (SPER), Jamia Hamdard University, New Delhi, India.
Anukrati AgnihotriSchool of Pharmaceutical Education and Research (SPER), Jamia Hamdard University, New Delhi, India.
Asfi RizwanSchool of Pharmaceutical Education and Research (SPER), Jamia Hamdard University, New Delhi, India.
Faizul HasanMetro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India.
Mohd Danish AnsariDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
Zarif Mohamed SofianDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
Nur Akmarina B M SaidDepartment of Pharmaceutical Life Sciences, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
Kenneth K W ToSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Syed MahmoodDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: CD4 Objective: This review aims to explore the immunological significance of CD4 Methods: A comprehensive analysis of CD4 Results: Novel drug delivery systems demonstrate significant potential in selectively modulating CD4 Conclusion: Novel drug delivery systems provide a versatile platform for precise CD4

Indexed as

cancer immunologyCD4+ T-cellsnanoformulationnovel drug delivery systemstumor microenvironment

Identifiers

PMID40860882
PMCPMC12375592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.